Alexander Burashnikov is a notable inventor based in New Hartford, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of atrial fibrillation. With a total of 3 patents to his name, Burashnikov's work is recognized for its innovative approaches to cardiovascular health.

Latest Patents

One of Burashnikov's latest patents is a method for treating atrial fibrillation. This invention involves the coadministration of a synergistically therapeutic amount of dronedarone or its pharmaceutically acceptable salts, along with ranolazine or its pharmaceutically acceptable salts. The method aims to treat or prevent atrial fibrillation and/or atrial flutter, while also providing ways to modulate ventricular and atrial rhythm and rate. Additionally, the invention includes pharmaceutical formulations suitable for such combined administration.

Career Highlights

Burashnikov is currently associated with Gilead Sciences, Inc., where he continues to develop innovative solutions in the medical field. His work has been instrumental in advancing treatment options for patients suffering from atrial fibrillation.

Collaborations

Some of his notable coworkers include Charles Antzelevitch and Luiz Belardinelli, who have collaborated with him on various projects related to cardiovascular health.

Conclusion

Alexander Burashnikov's contributions to the treatment of atrial fibrillation highlight his role as a leading inventor in the medical field. His innovative methods and collaborations continue to pave the way for advancements in patient care.

This text is generated by artificial intelligence and may not be accurate.